Leaderboard

En | De
Sie sind hier: Onkologie » Gynäkologische Tumoren 18. Mai 2026
Suchen
medline.ch
Gynäkologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 16440  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 328782  
   
Scrape versus imprint cytology in sentinel lymph nodes of breast cancer patients after neoadjuvant therapy: Does combination add value?
Cancer Cytopathol
Ak, Kadan E, K, Sadio, Seçinti , .
PMID: 42145150 [PubMed - indexed for MEDLINE]


Exploring the somatic mutational landscape of ovarian cancer in Estonia.
Acta Oncol
Tooming M, Rekker K, Toome K, Roht L, Laidre P, Fjodorova O, , Pajusalu S, Ilisson M, Peets P, Jõgi T, Klaup K, Ojamaa K, Niine-Roolaht EM, Kaarde P, Vettus E, Piirsoo J, Vahar H, Õunap K, Kahre T.
PMID: 42145025 [PubMed - indexed for MEDLINE]


Benign metastasizing leiomyoma: a systematic review of diagnosis, management, and outcomes.
Chin Clin Oncol
Karo, Szcz, Pi, Bornio E, Grabowski W, Plata H, Pa, Karo, Pi.
PMID: 42145021 [PubMed - indexed for MEDLINE]


A narrative review of the value of immunoinflammatory markers in the prognosis of endometrial carcinoma.
Chin Clin Oncol
Yin X, Zhang H, Zhang S.
PMID: 42145019 [PubMed - indexed for MEDLINE]


Is rechallenge with CDK4/6 inhibitors beyond progression reasonable for patients with hormone receptor-positive and HER2-negative advanced breast cancer?-a commentary on the PALMIRA trial.
Chin Clin Oncol
Shimura M, Mukohara T.
PMID: 42145011 [PubMed - in process]


First-line fulvestrant vs. anastrozole in hormone receptor-positive advanced breast cancer: insights from the final FALCON trial results.
Chin Clin Oncol
Takahashi Y, Nakamoto S, Tanioka M, Shien T.
PMID: 42145006 [PubMed - in process]


Refining Sentinel Lymph Node Biopsy Decisions for Clinically Node-Negative Microinvasive DCIS.
Breast J
Huang C, Parmar P, Habboosh N, Bhimani F, Chen Y, Entenberg D, Oktay M, Gupta A, Pastoriza J, McEvoy M, Feldman S.
PMID: 42144978 [PubMed - indexed for MEDLINE]


Effect of obesity and endocrine therapy on the prognosis of premenopausal women with HR+HER2-breast cancer: a multi-center retrospective study.
Sci Rep
Lian W, Hong C, Wang C, Chen D.
PMID: 42144406 [PubMed - indexed for MEDLINE]


Emerging trends in implication of nanocarriers in repolarization of tumor associated macrophages for improved triple negative breast cancer therapy.
Colloids Surf B Biointerfaces
Banjare N, Singh M, Kuiry A, Gupta PN.
PMID: 42143910 [PubMed - as supplied by publisher]


Copper (I) nicotinate complex potentiates chemotherapy-induced apoptosis in HCC-1806 triple negative breast cancer cells: An in vitro study.
J Inorg Biochem
Helal MA, Abdel-Mohsen MA, Toson EA.
PMID: 42143555 [PubMed - as supplied by publisher]


Latent profiles of parenting concerns and influencing factors among Chinese breast cancer mothers: a mixed-methods study.
Eur J Oncol Nurs
Zhang YH, Xu Q, Cao ZY, Ding M, Wang ZZ, Hong JF.
PMID: 42143437 [PubMed - as supplied by publisher]


Predictors of pathologic complete response in triple‑negative breast cancer treated with neoadjuvant chemotherapy: a systematic review and meta-analysis.
Clin Exp Med
Li X, Peng K, Li Q.
PMID: 42143190 [PubMed - as supplied by publisher]


Pre-treatment of cabozantinib prior to hypofractionated radiotherapy increases immunomodulatory effects and tumor size reduction in a 4T1 breast cancer murine model.
Sci Rep
Keshavarz F, Kouchaki A, Soltanshahi M, Jaafari MR, Mafi AR, Shabani M, Jalali SA.
PMID: 42143109 [PubMed - as supplied by publisher]


Betulinic acid is associated with miR-21 modulation, apoptosis and redox changes in breast cancer cells: an in vitro and in silico study.
Sci Rep
Mahmoud MA, Abdo H, Mekky M, Salem T, Mabrouk S, Khaled B.
PMID: 42143107 [PubMed - indexed for MEDLINE]


Circadian rhythms as orchestrators of breast cancer metastasis: From molecular mechanisms to chronotherapeutic interventions.
Cancer Lett
Sabit H, Ghazy A, Albogami KFKM, Abdelhadi OE, Abdel-Ghany S, Arneth B.
PMID: 42142702 [PubMed - as supplied by publisher]


"Neoadjuvant trastuzumab deruxtecan for high-risk HER2-positive early breast cancer: Does the evidence support its use as a new standard-of-care?".
Eur J Cancer
Conforti F, Sala I, Pala L, Bendoni M, Canzian J, Tinterri B, De Pas T, Locatelli M, Bagnardi V, Gelber R.
PMID: 42142430 [PubMed - as supplied by publisher]


An exploratory study on exposure to bisphenol A analogues and breast cancer risk.
Environ Int
Siddique S, Habibagahi A, Marro L, Bouraoui I, Kubwabo C, Harris SA.
PMID: 42142421 [PubMed - as supplied by publisher]


Increasing efficiency in the ACR Digital Mammography QC Manual's DBT Z-resolution evaluation.
J Appl Clin Med Phys
Fisher RF, Bevins NB, Hulme KW, Schaeffer C.
PMID: 42142398 [PubMed - indexed for MEDLINE]


Primary tumour resection reduces the risk of major local morbidity in de novo stage IV breast cancer: secondary data analysis from the JCOG1017 randomized controlled trial.
Br J Surg
Ishitobi M, Tanaka K, Shimomura A, Yamanaka T, Tsukioki T, Iwata H, Hara F, Fujisawa T, Sasaki K, Kajikawa R, Sakai T, Sagara Y, Shigematsu H, Ozaki Y, Nozawa K, Sudo K, Naito Y, Terata K, Ishiba T, Fukuda H, Shien T.
PMID: 42142363 [PubMed - as supplied by publisher]


Association of CA12 with calcification in ER+/HER-2 negative breast cancer.
Discov Oncol
Zhu Y, Du Q, Ma Y, Xu N, Luo Y, Liu D.
PMID: 42142233 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 328782    Seite 1 von 16440  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1